FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2068854073> ?p ?o ?g. }

• W2068854073 endingPage "1300" @default.
• W2068854073 startingPage "1291" @default.
• W2068854073 abstract "Primary human hepatocytes in culture are commonly used to evaluate cytochrome P450 (P450) induction via an enzyme activity endpoint. However, other processes can confound data interpretation. To this end, the impact of time-dependent P450 inhibition in this system was evaluated. Using a substrate-cassette approach, P450 activities were determined after incubation with the prototypic inhibitors tienilic acid (CYP2C9), erythromycin, troleandomycin, and fluoxetine (CYP3A4). Kinetic analysis of enzyme inactivation in hepatocytes was used to describe the effect of these time-dependent inhibitors and derive the inhibition parameters kinact and KI) which generally were in good agreement with the values derived using recombinant P450s and human liver microsomes (HLMs). Tienilic acid selectively inhibited CYP2C9-dependent diclofenac 4'-hydroxylation activity, and erythromycin, troleandomycin, and fluoxetine inhibited CYP3A4-dependent midazolam 1'-hydroxylation in a time- and concentration-dependent manner. Fluoxetine also inhibited CYP2C19-dependent S-mephenytoin 4'-hydroxylation in a time- and concentration-dependent manner in hepatocytes, HLMs, and recombinant CYP2C19 (KI 0.4 microM and kinact 0.5 min(-1)). As expected, the effect of fluoxetine on CYP2D6 in hepatocytes was consistent with potent yet reversible inhibition. A very weak time-dependent CYP2C9 inhibitor (AZ1, a proprietary AstraZeneca compound; KI 30 microM and kinact 0.02 min(-1)) effectively abolished CYP2C9 activity over 24 h at low (micromolar) concentrations in primary cultured human hepatocytes. This work demonstrates that caution is warranted in the interpretation of enzyme induction studies with metabolically stable, weak time-dependent inhibitors, which may have dramatic inhibitory effects on P450 activity in this system. Therefore, in addition to enzyme activity, mRNA and/or protein levels should be measured to fully evaluate the P450 induction potential of a drug candidate." @default.
• W2068854073 created "2016-06-24" @default.
• W2068854073 creator A5028468962 @default.
• W2068854073 creator A5052533801 @default.
• W2068854073 creator A5061830171 @default.
• W2068854073 creator A5061968774 @default.
• W2068854073 creator A5079424977 @default.
• W2068854073 date "2006-05-05" @default.
• W2068854073 modified "2023-10-12" @default.
• W2068854073 title "EVALUATION OF TIME-DEPENDENT CYTOCHROME P450 INHIBITION USING CULTURED HUMAN HEPATOCYTES" @default.
• W2068854073 cites W1971106062 @default.
• W2068854073 cites W1972327861 @default.
• W2068854073 cites W1986838867 @default.
• W2068854073 cites W1990652438 @default.
• W2068854073 cites W1995089209 @default.
• W2068854073 cites W1996141149 @default.
• W2068854073 cites W2001753147 @default.
• W2068854073 cites W2011863821 @default.
• W2068854073 cites W2015185599 @default.
• W2068854073 cites W2022133983 @default.
• W2068854073 cites W2023198390 @default.
• W2068854073 cites W2035168432 @default.
• W2068854073 cites W2036283577 @default.
• W2068854073 cites W2037461646 @default.
• W2068854073 cites W2042296332 @default.
• W2068854073 cites W2045654730 @default.
• W2068854073 cites W2061108237 @default.
• W2068854073 cites W2089338956 @default.
• W2068854073 cites W2090365405 @default.
• W2068854073 cites W2098154721 @default.
• W2068854073 cites W2099352274 @default.
• W2068854073 cites W2103946220 @default.
• W2068854073 cites W2109122105 @default.
• W2068854073 cites W2112416492 @default.
• W2068854073 cites W2116796907 @default.
• W2068854073 cites W2125270482 @default.
• W2068854073 cites W2128255233 @default.
• W2068854073 cites W2137442330 @default.
• W2068854073 cites W2138859054 @default.
• W2068854073 cites W2143980519 @default.
• W2068854073 cites W2151556849 @default.
• W2068854073 cites W2154310483 @default.
• W2068854073 cites W2162287902 @default.
• W2068854073 cites W261235034 @default.
• W2068854073 cites W4210584679 @default.
• W2068854073 cites W4249191875 @default.
• W2068854073 doi "https://doi.org/10.1124/dmd.106.009969" @default.
• W2068854073 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16679385" @default.
• W2068854073 hasPublicationYear "2006" @default.
• W2068854073 type Work @default.
• W2068854073 sameAs 2068854073 @default.
• W2068854073 citedByCount "96" @default.
• W2068854073 countsByYear W20688540732012 @default.
• W2068854073 countsByYear W20688540732013 @default.
• W2068854073 countsByYear W20688540732014 @default.
• W2068854073 countsByYear W20688540732015 @default.
• W2068854073 countsByYear W20688540732016 @default.
• W2068854073 countsByYear W20688540732017 @default.
• W2068854073 countsByYear W20688540732018 @default.
• W2068854073 countsByYear W20688540732019 @default.
• W2068854073 countsByYear W20688540732020 @default.
• W2068854073 countsByYear W20688540732021 @default.
• W2068854073 countsByYear W20688540732022 @default.
• W2068854073 crossrefType "journal-article" @default.
• W2068854073 hasAuthorship W2068854073A5028468962 @default.
• W2068854073 hasAuthorship W2068854073A5052533801 @default.
• W2068854073 hasAuthorship W2068854073A5061830171 @default.
• W2068854073 hasAuthorship W2068854073A5061968774 @default.
• W2068854073 hasAuthorship W2068854073A5079424977 @default.
• W2068854073 hasConcept C109650736 @default.
• W2068854073 hasConcept C181199279 @default.
• W2068854073 hasConcept C185592680 @default.
• W2068854073 hasConcept C2776980637 @default.
• W2068854073 hasConcept C2781109383 @default.
• W2068854073 hasConcept C526171541 @default.
• W2068854073 hasConcept C55493867 @default.
• W2068854073 hasConcept C86745063 @default.
• W2068854073 hasConcept C86803240 @default.
• W2068854073 hasConcept C87644729 @default.
• W2068854073 hasConcept C98274493 @default.
• W2068854073 hasConceptScore W2068854073C109650736 @default.
• W2068854073 hasConceptScore W2068854073C181199279 @default.
• W2068854073 hasConceptScore W2068854073C185592680 @default.
• W2068854073 hasConceptScore W2068854073C2776980637 @default.
• W2068854073 hasConceptScore W2068854073C2781109383 @default.
• W2068854073 hasConceptScore W2068854073C526171541 @default.
• W2068854073 hasConceptScore W2068854073C55493867 @default.
• W2068854073 hasConceptScore W2068854073C86745063 @default.
• W2068854073 hasConceptScore W2068854073C86803240 @default.
• W2068854073 hasConceptScore W2068854073C87644729 @default.
• W2068854073 hasConceptScore W2068854073C98274493 @default.
• W2068854073 hasIssue "8" @default.
• W2068854073 hasLocation W20688540731 @default.
• W2068854073 hasLocation W20688540732 @default.
• W2068854073 hasOpenAccess W2068854073 @default.
• W2068854073 hasPrimaryLocation W20688540731 @default.
• W2068854073 hasRelatedWork W1998541081 @default.
• W2068854073 hasRelatedWork W2057322399 @default.

• next